Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses
Biotechnology and Bioengineering · 2023-09 · 120 (9) · 2658-2671
DOI: 10.1002/bit.28392 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2023-09. Written by Esmeralda Cuevas-Juárez and 7 co-authors. Institution: Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Morelos, Mexico. Major MEDLINE topics: Zika Virus, Zika Virus Infection, Dengue Virus, Dengue. Cited 12 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México.
Abstract (original language)
Vaccine development against dengue virus is challenging because of the antibody‐dependent enhancement of infection (ADE), which causes severe disease. Consecutive infections by Zika (ZIKV) and/or dengue viruses (DENV), or vaccination can predispose to ADE. Current vaccines and vaccine candidates contain the complete envelope viral protein, with epitopes that can raise antibodies causing ADE. We used the envelope dimer epitope (EDE), which induces neutralizing antibodies that do not elicit ADE, to design a vaccine against both flaviviruses. However, EDE is a discontinuous quaternary epitope that cannot be isolated from the E protein without other epitopes. Utilizing phage display, we selected three peptides that mimic the EDE. Free mimotopes were disordered and did not elicit an immune response. After their display on adeno‐associated virus (AAV) capsids (VLP), they recovered their structure and were recognized by an EDE‐specific antibody. Characterization by cryo‐EM and enzyme‐linked immunosorbent assay confirmed the correct display of a mimotope on the surface of the AAV VLP and its recognition by the specific antibody. Immunization with the AAV VLP displaying one of the mimotopes induced antibodies that recognized ZIKV and DENV. This work provides the basis for developing a Zika and dengue virus vaccine candidate that will not induce ADE.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Morelos, Mexico.
- National Center for In-situ Tomographic Ultramicroscopy, Simons Electron Microscopy Center, New York Structural Biology Center, New York, New York, USA.
Funding
- Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
Cite
APA
Cuevas-Juárez, E., Liñan-Torres, A., Hernández, C., Kopylov, M., Potter, C. S., Carragher, B., Ramírez, O. T., & Palomares, L. A. (2023). Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28392
Vancouver
Cuevas-Juárez E, Liñan-Torres A, Hernández C, Kopylov M, Potter CS, Carragher B, et al. Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28392
BibTeX
@article{CuevasJurez2023,
author = {Cuevas-Juárez, Esmeralda and Liñan-Torres, Arturo and Hernández, Carolina and Kopylov, Mykhailo and Potter, Clint S and Carragher, Bridget and Ramírez, Octavio T and Palomares, Laura A},
title = {Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28392}
}
EUVIMED